Eprex and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Eprex (epoetin alfa), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Lasix, and have Anaemia.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Eprex. It is created by eHealthMe based on reports of 5,531 people who have side effects when taking Eprex from the FDA, and is updated regularly.

What is Eprex?

Eprex has active ingredients of epoetin alfa. eHealthMe is studying from 5,554 Eprex users. Check the latest studies of Eprex.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,068 drugs and 914 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

On Jul, 28, 2026

5,531 people reported to have side effects when taking Eprex.
Among them, 20 people (0.36%) have Neoplasm progression.

Among these 20 people:

How long have people been on Eprex when they have Neoplasm progression? *

What is the gender of people who have Neoplasm progression when taking Eprex? *

female: 78.95 %
male: 21.05 %

What is the age of people who have Neoplasm progression when taking Eprex? *

What are other drugs people take besides Eprex? *

Cancidas: 14 people, 70.00%
Vepesid: 14 people, 70.00%
Valtrex: 14 people, 70.00%
Aldactone: 14 people, 70.00%
Norvasc: 14 people, 70.00%
Cubicin: 14 people, 70.00%
Lasix: 14 people, 70.00%
Prednisone: 7 people, 35.00%
Chlorpheniramine Maleate: 7 people, 35.00%
Cisplatin: 7 people, 35.00%

What are other side effects people have besides Neoplasm progression? *

Diffuse Large B-Cell Lymphoma Refractory (cancer of b cells, a type of white blood cell-relapsed): 14 people, 70.00%
Disease Progression: 8 people, 40.00%
Acute Kidney Failure: 2 people, 10.00%
Prostate Cancer Metastatic: 2 people, 10.00%
Weakness: 1 person, 5.00%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 5.00%
Anaemia (lack of blood): 1 person, 5.00%
Blood Creatinine Increased: 1 person, 5.00%
Cholecystitis Acute (rapid infection of gallbladder): 1 person, 5.00%
Death: 1 person, 5.00%

What are the existing conditions these people have? *

Anaemia (lack of blood): 13 people, 65.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 11 people, 55.00%
Leukopenia (less number of white blood cells in blood): 11 people, 55.00%
High Blood Pressure: 11 people, 55.00%
Prostate Cancer Metastatic: 2 people, 10.00%
Oedema (fluid collection in tissue): 2 people, 10.00%
Metastases To Bone (cancer spreads to bone): 2 people, 10.00%
Constipation: 2 people, 10.00%
Cancer Pain: 2 people, 10.00%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Eprex and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eprex:

Eprex (5,554 reports)

Browse all side effects of Eprex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Neoplasm progression (1,068 drugs)

Browse all the conditions that are associated with Neoplasm progression:

Neoplasm progression (914 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on epoetin alfa (the active ingredients of Eprex) and Eprex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.